Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PP1PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000251.3:c.366+1G>C variant is in the dinucleotide of canonical donor splice site of exon 2, and predicted by SpliceAI to cause exon 2 skipping leading to a frameshift, p.(Ala72Phefs*9) (PVS1 met). Segregation analysis of pedigree data shows odds of pathogenicity = 3.23 (Australian Colon Cancer Family Registry) (>2.08; PP1 met). The variant is absent in gnomAD v2.1, v3.1 and v4.1 (PM2_Supporting met). Therefore, this variant meets the criteria to be classified as Likely Pathogenic. (VCEP specifications version 1) LINK:https://erepo.genome.network/evrepo/ui/classification/CA346730170/MONDO:0007356/137
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function. -